According to Sino Biopharmaceutical's latest financial reports the company's total liabilities are $4.02 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $3.78 B | 5.78% |
2021-12-31 | $3.58 B | -5.81% |
2020-12-31 | $3.80 B | 56.62% |
2019-12-31 | $2.42 B | 48.32% |
2018-12-31 | $1.63 B | 27.87% |
2017-12-31 | $1.27 B | 15.3% |
2016-12-31 | $1.10 B | 42.1% |
2015-12-31 | $0.78 B | 13.13% |
2014-12-31 | $0.69 B | 94.85% |
2013-12-31 | $0.35 B | 43.15% |
2012-12-31 | $0.24 B | 34.17% |
2011-12-31 | $0.18 B | 8.49% |
2010-12-31 | $0.17 B | 78.65% |
2009-12-31 | $95.17 M | 19.66% |
2008-12-31 | $79.53 M | 71.17% |
2007-12-31 | $46.46 M | 97.01% |
2006-12-31 | $23.58 M | 10.81% |
2005-12-31 | $21.28 M | -41.59% |
2004-12-31 | $36.44 M | 17.89% |
2003-12-31 | $30.91 M | 40.61% |
2002-12-31 | $21.98 M | 86.76% |
2001-12-31 | $11.77 M |